Estudo randomizado | Toripalimabe com quimioterapia para pacientes com câncer de pulmão de não pequenas células avançado e sem tratamento. 17 Out, 2022 | 12:46h Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01) – Journal of Clinical Oncology Comentário: CHOICE-01: Toripalimab Plus Chemotherapy Improves Survival in Advanced NSCLC Without Actionable Mutations – The ASCO Post